| 1 |
34236783 | Rapamycin and Paclitaxel Affect Human Aortic Smooth Muscle Cells-Derived Foam Cells Viability and Proliferation. | 2022 May 2 |
1 |
| 2 |
34715309 | Effects of miRNAs in exosomes derived from α-synuclein overexpressing SH-SY5Y cells on autophagy and inflammation of microglia. | 2022 Jan |
1 |
| 3 |
34936813 | Mammalian Target of Rapamycin Inhibitor Rapamycin Alleviates 7-Ketocholesterol Induced Inflammatory Responses and Vascular Endothelial Growth Factor Elevation by Regulating MAPK Pathway in Human Retinal Pigment Epithelium Cells. | 2022 Mar |
1 |
| 4 |
35488725 | Increased mTORC2 pathway activation in lymph nodes of iMCD-TAFRO. | 2022 Jun |
1 |
| 5 |
35563682 | Short-Term Autophagy Preconditioning Upregulates the Expression of COX2 and PGE2 and Alters the Immune Phenotype of Human Adipose-Derived Stem Cells In Vitro. | 2022 Apr 19 |
3 |
| 6 |
35571122 | Effect of Combined Mycophenolate and Rapamycin Treatment on Kidney Fibrosis in Murine Lupus Nephritis. | 2022 |
1 |
| 7 |
33957967 | Decreased microRNA-155 in Behcet's disease leads to defective control of autophagy thereby stimulating excessive proinflammatory cytokine production. | 2021 May 6 |
1 |
| 8 |
34164408 | HMGB1 Activates Myeloid Dendritic Cells by Up-Regulating mTOR Pathway in Systemic Lupus Erythematosus. | 2021 |
1 |
| 9 |
31264496 | Interruption of Autophagosome Formation in Cardiovascular Disease, an Evidence for Protective Response of Autophagy. | 2020 Apr |
1 |
| 10 |
32103032 | p38 MAPK signalling regulates cytokine production in IL-33 stimulated Type 2 Innate Lymphoid cells. | 2020 Feb 26 |
2 |
| 11 |
32206779 | Increased mTOR activation in idiopathic multicentric Castleman disease. | 2020 May 7 |
1 |
| 12 |
32434116 | Corrigendum to "Rapamycin suppresses TLR4-triggered IL-6 and PGE2 production of colon cancer cells by inhibiting TLR4 expression and NF-κB activation" [Mol. Immunol. 45 (2008) 2929-2936]. | 2020 May 17 |
1 |
| 13 |
33031791 | Rapamycin as a potential repurpose drug candidate for the treatment of COVID-19. | 2020 Nov 1 |
1 |
| 14 |
30703123 | Individual response to mTOR inhibition in delaying replicative senescence of mesenchymal stromal cells. | 2019 |
1 |
| 15 |
30747999 | Curcumin reduces development of seizurelike events in the hippocampal-entorhinal cortex slice culture model for epileptogenesis. | 2019 Apr |
1 |
| 16 |
31645839 | The mTOR kinase inhibitor rapamycin enhances the expression and release of pro-inflammatory cytokine interleukin 6 modulating the activation of human microglial cells. | 2019 |
1 |
| 17 |
31885770 | Adipose-Derived Mesenchymal Stem Cells Isolated from Patients with Abdominal Aortic Aneurysm Exhibit Senescence Phenomena. | 2019 |
1 |
| 18 |
29348392 | Rapamycin prevents the intervertebral disc degeneration via inhibiting differentiation and senescence of annulus fibrosus cells. | 2018 Jan 18 |
1 |
| 19 |
29772587 | Anti-inflammatory Effects of Cardamonin in Ovarian Cancer Cells Are Mediated via mTOR Suppression. | 2018 Nov |
1 |
| 20 |
28804534 | mTOR Inhibition Rejuvenates the Aging Gingival Fibroblasts through Alleviating Oxidative Stress. | 2017 |
1 |
| 21 |
28894133 | 5-methoxytryptophan protects MSCs from stress induced premature senescence by upregulating FoxO3a and mTOR. | 2017 Sep 11 |
1 |
| 22 |
26879559 | Interleukin-6-stimulated progranulin expression contributes to the malignancy of hepatocellular carcinoma cells by activating mTOR signaling. | 2016 Feb 16 |
1 |
| 23 |
27350635 | Th1, Th2 and Th17 Cytokine Profile in Patients with Multiple Sclerosis Following Treatment with Rapamycin. | 2016 Jun |
1 |
| 24 |
27871466 | Autophagy protects against oxidized low density lipoprotein-mediated inflammation associated with preeclampsia. | 2016 Dec |
1 |
| 25 |
27904683 | Rapamycin targets Interleukin 6 (IL-6) expression and suppresses endothelial cell invasion stimulated by tumor cells. | 2016 |
2 |
| 26 |
25653476 | Rapamycin improves palmitate-induced ER stress/NF κ B pathways associated with stimulating autophagy in adipocytes. | 2015 |
1 |
| 27 |
25942007 | mTORC1 Regulates Flagellin-Induced Inflammatory Response in Macrophages. | 2015 |
1 |
| 28 |
26652669 | Rapamycin reduces fibroblast proliferation without causing quiescence and induces STAT5A/B-mediated cytokine production. | 2015 |
1 |
| 29 |
24910242 | Liver damage, inflammation, and enhanced tumorigenesis after persistent mTORC1 inhibition. | 2014 Jul 1 |
2 |
| 30 |
23308138 | Profiling sirolimus-induced inflammatory syndrome: a prospective tricentric observational study. | 2013 |
1 |
| 31 |
22132896 | Preconditioning donor with a combination of tacrolimus and rapamacyn to decrease ischaemia-reperfusion injury in a rat syngenic kidney transplantation model. | 2012 Jan |
1 |
| 32 |
20828737 | Role of the mTOR pathway in LPS-activated monocytes: influence of hypertonic saline. | 2011 Dec |
1 |
| 33 |
19879324 | p70 S6 kinase limits tumor necrosis factor-alpha-induced interleukin-6 synthesis in osteoblast-like cells. | 2010 Feb 5 |
1 |
| 34 |
20371718 | Dual inhibition of akt/mammalian target of rapamycin pathway by nanoparticle albumin-bound-rapamycin and perifosine induces antitumor activity in multiple myeloma. | 2010 Apr |
1 |
| 35 |
20430366 | Gingival overgrowth in cyclosporine, tacrolimus, or sirolimus-based immunosuppressive regimens and the single nucleotide IL-6 (-174 G/C) gene polymorphism. | 2010 Jul |
1 |
| 36 |
20844194 | Combined administration of a mutant TGF-beta1/Fc and rapamycin promotes induction of regulatory T cells and islet allograft tolerance. | 2010 Oct 15 |
1 |
| 37 |
19131641 | Participation of mammalian target of rapamycin complex 1 in Toll-like receptor 2- and 4-induced neutrophil activation and acute lung injury. | 2009 Aug |
1 |
| 38 |
17993646 | Regulation of interleukin-6-induced hepatic insulin resistance by mammalian target of rapamycin through the STAT3-SOCS3 pathway. | 2008 Jan 11 |
4 |
| 39 |
18343502 | Rapamycin suppresses TLR4-triggered IL-6 and PGE(2) production of colon cancer cells by inhibiting TLR4 expression and NF-kappaB activation. | 2008 May |
2 |
| 40 |
17322416 | Anti-atherosclerotic effects of sirolimus on human vascular smooth muscle cells. | 2007 Jun |
1 |
| 41 |
17880416 | Effects of ciclosporin A, tacrolimus and sirolimus on cytokine production in neonatal immune cells. | 2007 Oct |
3 |
| 42 |
17996694 | Rapamycin inhibits differentiation of Th17 cells and promotes generation of FoxP3+ T regulatory cells. | 2007 Dec 15 |
1 |
| 43 |
16005497 | Early elevation of interleukin-1beta and interleukin-6 levels after bare or drug-eluting stent implantation in patients with stable angina. | 2006 |
1 |
| 44 |
15769938 | Effects of sirolimus on mesangial cell cholesterol homeostasis: a novel mechanism for its action against lipid-mediated injury in renal allografts. | 2005 Jul |
1 |
| 45 |
15070696 | Rapamycin sensitizes multiple myeloma cells to apoptosis induced by dexamethasone. | 2004 Apr 15 |
2 |
| 46 |
11872747 | Signal pathways involved in activation of p70S6K and phosphorylation of 4E-BP1 following exposure of multiple myeloma tumor cells to interleukin-6. | 2002 May 3 |
3 |
| 47 |
9373220 | Rapamycin antagonizes interleukin-6 mediated growth arrest and differentiation of myeloblastic M1 cells. | 1997 Nov |
4 |
| 48 |
8805102 | In vitro effects of immunosuppressive agents on cytokine production by HTLV-I-infected T cell clones derived from the ocular fluid of patients with HTLV-I uveitis. | 1996 |
1 |
| 49 |
8004821 | Effects of cyclosporine and rapamycin on immunoglobulin production by preactivated human B cells. | 1994 Jun |
1 |
| 50 |
7507316 | Immunosuppressants: tools to investigate the physiological role of cytokines. | 1993 Nov |
1 |